Massachusetts Financial Services’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-611,039
| Closed | -$11.5M | – | 860 |
|
|
2019
Q3 | $11.5M | Sell |
611,039
-322,561
| -35% | -$6.08M | ﹤0.01% | 595 |
|
|
2019
Q2 | $11M | Buy |
933,600
+5,409
| +0.6% | +$63.7K | ﹤0.01% | 615 |
|
|
2019
Q1 | $12.7M | Buy |
928,191
+175,389
| +23% | +$2.39M | 0.01% | 587 |
|
|
2018
Q4 | $7.72M | Buy |
752,802
+15,514
| +2% | +$159K | ﹤0.01% | 631 |
|
|
2018
Q3 | $12.3M | Sell |
737,288
-110
| -0% | -$1.83K | 0.01% | 593 |
|
|
2018
Q2 | $11.7M | Buy |
737,398
+69,327
| +10% | +$1.1M | 0.01% | 610 |
|
|
2018
Q1 | $8.49M | Buy |
668,071
+364,580
| +120% | +$4.63M | ﹤0.01% | 637 |
|
|
2017
Q4 | $3.48M | Buy |
303,491
+3,973
| +1% | +$45.5K | ﹤0.01% | 679 |
|
|
2017
Q3 | $3.67M | Buy |
299,518
+151,809
| +103% | +$1.86M | ﹤0.01% | 671 |
|
|
2017
Q2 | $1.69M | Sell |
147,709
-31
| -0% | -$355 | ﹤0.01% | 718 |
|
|
2017
Q1 | $3.07M | Sell |
147,740
-233
| -0.2% | -$4.85K | ﹤0.01% | 681 |
|
|
2016
Q4 | $3.08M | Sell |
147,973
-377
| -0.3% | -$7.84K | ﹤0.01% | 695 |
|
|
2016
Q3 | $4.86M | Buy |
148,350
+2,509
| +2% | +$82.2K | ﹤0.01% | 651 |
|
|
2016
Q2 | $3.64M | Sell |
145,841
-45,641
| -24% | -$1.14M | ﹤0.01% | 676 |
|
|
2016
Q1 | $4.69M | Buy |
191,482
+5,684
| +3% | +$139K | ﹤0.01% | 646 |
|
|
2015
Q4 | $6.14M | Sell |
185,798
-134,885
| -42% | -$4.46M | ﹤0.01% | 628 |
|
|
2015
Q3 | $10.5M | Buy |
320,683
+70,683
| +28% | +$2.32M | 0.01% | 589 |
|
|
2015
Q2 | $13.2M | Buy |
+250,000
| New | +$13.2M | 0.01% | 579 |
|